Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Recipharm AB is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Rare Disease
Metabolic
Quick Facts
HQ:France
Founded:2015
Employees:2,842
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Biologics Manufacturing
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Prefilled Syringe
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval KII0BN
Health Canada · #APR-066YQXLH · 2021-07-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-KZ6FTZSK
Issued: 2020-12-15
Expires: 2025-03-13
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-AU9SPX8O
Issued: 2020-10-05
Expires: 2025-04-12
Loading CDMO intelligence...
Key facts about Recipharm AB
- Recipharm AB is headquartered in France.
- Recipharm AB was founded in 2015.
- Recipharm AB has 2,842 employees.
- Recipharm AB's capabilities include Biologics Drug Substance, Biologics Drug Product and Biologics Manufacturing.
Find CDMOs like Recipharm AB
Directory pages this company appears in, each with the full list of matching manufacturers.